• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
KZA

KAZIA THERAPEUTICS LIMITED - Corporate Spotlight

0.00% ! 8.0¢
Currently unlisted.
Add to My Watchlist

Kazia Therapeutics Limited is an Australia-based oncology-focused drug development... Kazia Therapeutics Limited is an Australia-based oncology-focused drug development company. The Company is engaged in pharmaceutical research and development. The Company’s drug candidates are designed to treat diseases such as brain cancer, renal cancer, and liver cancer. The Company’s lead programs include paxalisib and EVT801. Paxalisib is a small molecule inhibitor of the PI3K / Akt / mTOR pathway, a central regulator of growth and cell division that is dysregulated in many types of cancer. Paxalisib is being developed for several forms of brain cancer. EVT801 is a small molecule inhibitor of VEGFR3. EVT801 is being developed in patients with advanced cancer. EVT801 targets angiogenesis, the formation of new blood vessels around a tumor.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

No Corporate Spotlight currently available.

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Top Stories

HotCopper Highlights: 4DS Memory's strategic review flags strategic review & more

Good Afternoon and welcome to HotCopper Highlights for Week 36, I’m Jon Davidson. In this segment the stocks you were watching and discussing the most this week on Australia’s number 1 finance website, let’s kick off with the most viewed.4DS Memory ...
Listen: HotCopper Wire Podcast 023 – Glowing gold, shining silver, and... wheat collusion? In this HotCopper Wire episode, we look at surging gold and silver as well as Trump's appeals court clash, and a wheat futures conspiracy.
Peak Rare Earths jumps +26% as Shenghe Res imply valuation just shy of $200M Peak Rare Earths (ASX:PEK) shareholders on the HotCopper forums were almost universally pleased on Friday after the company confirmed it had worked out a better takeover deal than originally received from Singapore-based Shenghe Resources, with the latter now acquiring 100% of Peak at a 32% premi...
4DS Memory becomes a penny stock as company walks away from key tech partners Share a thought for 4DS Memory (ASX:4DS) shareholders on Friday, who have seen shares fall -70% after patiently waiting for the company to come out of a self-imposed suspension it ordered when it missed its own deadline for a strategic review.The company is now at an all time low and has dipped b...
Market Close: Sweet relief! XJO green on Thursday – but can Wall Street keep climbing? Good Afternoon and welcome to HotCopper’s Market Close for Thursday 4th of September, I’m Jon Davidson. Sweet relief today with the market in the green once more back over 8,800pts for much of intraday trade after tech investors in the US felt a little better overn...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.